XBI
- SPDR S&P Biotech ETFWichtige Informationen
| Frühestes Datum | 2006-02-06 |
ETF-Informationen
| Fondsanbieter | State Street |
| Index | S&P Biotechnology Select Industry |
| Kostenquote | 0.35% |
| Anzahl der Positionen | 140 |
| Auflagedatum | 2006-01-31 |
| Asset-Klasse | Equity |
| Notierung | US-listed |
| Sektor | Healthcare |
| Anlagestil | Growth |
| Nicht gehebelt | Non-leveraged |
Über XBI
The SPDR S&P Biotech ETF (XBI) provides exposure to the biotechnology sector in the United States, offering a diversified portfolio of mid-cap and small-cap securities. The fund tracks the S&P Biotechnology Select Industry Index, using an equal-weighted methodology to balance assets across all components. This ETF is suitable for investors seeking to fine-tune their exposure to the health care sector or those bullish on biotechnology over the long run.